PureTech Health launches new immuno-oncology programme

This article was originally published here

PureTech Health has launched a new immuno-oncology programme to develop monoclonal antibodies to target newly discovered immunosuppressive mechanisms in pancreatic cancer and other solid tumours.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply